Skip to content
healthcare.dev

Guaifenesin 600 mg

NDC 43598-008, Guaifenesin, tablet, extended release, from Dr. Reddy's Laboratories Inc..

Product NDC
43598-008
Status
Listed
Labeler
Dr. Reddy's Laboratories Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA215932
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
43598-008-01435980008015 BLISTER PACK in 1 CARTON (43598-008-01) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (43598-008-20)
43598-008-40435980008402 BLISTER PACK in 1 CARTON (43598-008-40) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (43598-008-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43598-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.